Golden Retriever

  • The Golden Retriever is a 0.014’’ wire tube equipped with a soft tip that is advanced and positioned inside the clot independent of a micro-catheter.
  • The Golden Retriever’s deployment mechanism unfolds six “crown” like elements, each composed of 12 micro-strands which engage the clot by rotational movement.
  • Full extension of the micro-strands forms five engagement zones for efficient clot retrieval.






Golden Retriever – New approach for blood clot retrieval

The Golden retriever is the future of fast and efficient blood clot retrieval. The Unique design is the thinnest on the market today, navigating like a wire to the clot, it retrieves the clot exerting minimal radial force on the vessel wall.

Since the publication of MR CLEAN, ESCAPE, Swift Prime, REVASCAT and EXTEND-IA, the number of mechanical thrombectomy procedures performed annually has increased by 80% and is expected to reach 60,000 in the U.S. by 2020, up from 18,000  in 2015.

The American Heart and Brain Association’s new guidelines establish the addition of Mechanical Retriever Technology as the frontline treatment for patients suffering a stroke. In its yearly innovation summit, the Cleveland Clinic chose the neuro blood clot retrieval market as one of the most uprising markets in 2016, expected to peak in the next two years.

Competitive Advantages

Superior technology

  • Engagement mechanism relies on cage formation enhancing the grip on the clot regardless of clot morphology and length.
  • Enables enhanced clot engagement.
  • Device deployment is independent of a microcatheter.
  • One size device suits all clots.
  • Reduced friction within the micro-catheter.

Reduced puncture to revascularization time

  • The smallest device diameter on the market (0.014”).
  • Improved delivery in tortuous anatomy.
  • No need to wait between deployment and retrieval.

Enhanced Safety Mechanism

  • Engagement and retrieval do not rely on radial force, thus minimizing vessel injury risk.
  • Capturing zones trap the clot from all sides simultaneously reinforcing it and preventing fragmentation and emboli risk.

Amnis Therapeutics Ltd.

22 Ha’ilan Street

P.O. Box 146,

Or Akiva.

3060000 Israel

T +972 72 22 00 330

F +972 72 22 00 346